Kolon Life Science Publishes Preclinical Results of Anticancer Gene Therapy Candidate KLS-3021 in International Journal
Simultaneous Inhibition of Primary Tumor and Lymph Node Metastasis in Skin Cancer Confirmed
Kolon Life Science has published the preclinical research results of its anticancer gene therapy candidate KLS-3021 for cutaneous squamous cell carcinoma (cSCC) in an international academic journal.
Kolon Life Science announced on the 27th that the preclinical research results of KLS-3021 for cutaneous squamous cell carcinoma have been officially published in the international journal for cell and gene therapy, "Molecular Therapy Oncology." KLS-3021 is an anticancer gene therapy candidate that utilizes a recombinant vaccinia virus with enhanced cancer cell selectivity, loaded with therapeutic genes (PH-20, IL-12, and sPD1-Fc).
In the study, KLS-3021 demonstrated high cancer cell-selective cytotoxicity and viral replication capacity in cSCC cell lines compared to normal cells. In metastatic models, a single intratumoral administration led to a reduction in primary tumor size as well as inhibition of tumor progression in metastatic lymph node lesions. It was also observed that the virus continued to spread at metastatic sites.
Analysis of the tumor microenvironment revealed histological evidence of hyaluronan degradation, extensive viral spread, increased immune cell infiltration, and immunogenic cell death. These results suggest that KLS-3021 can simultaneously target both the physical and immunological barriers of tumors.
Kolon Life Science is expanding the scope of KLS-3021 research to include prostate cancer, head and neck squamous cell carcinoma (HNSCC), and triple-negative breast cancer (TNBC), and plans to release the results through publications and conference presentations to facilitate discussions on global joint development and technology transfer.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
Lee Hankook, CEO of Kolon Life Science, stated, "This publication is an internationally recognized achievement demonstrating the therapeutic potential of KLS-3021 in advanced and metastatic cutaneous squamous cell carcinoma," adding, "We will accelerate both the expansion of indications and discussions on global commercialization."
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.